A new study reveals that the majority of macrophages in established atherosclerotic lesions are derived from local proliferation, rather than from the influx of blood-borne monocytes. While the factors driving proliferation remain to be understood, the findings suggest that targeting macrophage proliferation could represent a new therapeutic opportunity in established atherosclerosis.